Latest Partnerships News

Algorae Pharmaceuticals has signed a binding term sheet with India’s Cadila Pharmaceuticals to introduce two generic medicines targeting cardiovascular and metabolic disorders in Australia and New Zealand.

Race Oncology showcased compelling preclinical data at ESMO 2025 revealing that their drug RC220, combined with doxorubicin, not only shields the heart from toxicity but also boosts anticancer effects, supporting ongoing clinical trials.

Orthocell has boosted its investment in Marine Biomedical to secure exclusive global distribution rights for PearlBone™, an innovative bone substitute nearing FDA approval, enhancing its regenerative medicine portfolio.

BrainChip Holdings Ltd showcased its leadership in ultra-low-power edge AI technology, emphasizing strong partnerships and a growing product portfolio targeting high-growth sectors like defense and healthcare.

Prodigy Gold has reported a milestone with over one million ounces of gold in its resource inventory, alongside significant exploration progress and a successful $7.13 million capital raise to fund ongoing development.

Ausgold Limited has completed a $35 million capital raising and acquired critical freehold land, resolving a long-standing legal dispute and enabling a re-optimisation of its Katanning Gold Project mine plan. This strategic move sets the stage for an extensive drilling campaign and advances the project toward a final investment decision in mid-2026.

Andrew Schwartz, Qualitas’ Group Managing Director and Co-Founder, has sold 15.1 million shares to a major global equities manager, marking his first share sale since the IPO while retaining significant control. The move coincides with strong FY25 results and an accelerating FY26 pipeline.

Orpheus Uranium has gained crucial consent from the Adnyamathanha native title holders for a mining agreement that clears the way for drilling at its Frome and Maree uranium projects in South Australia.

Zip Co Limited has reported a near doubling in cash earnings for Q1 FY26, driven by robust transaction growth and improved operating leverage, particularly in the US market. The company also doubled its share buy-back program and raised its US transaction volume growth guidance.

Alicanto Minerals reports promising early-stage exploration results from its Greater Falun and Sala projects in Sweden, highlighting high-grade assays and new targets that reinforce the region's mineral potential.

Dreadnought Resources has commenced drilling at the Stinger rare earth and niobium target within its Mangaroon project, revealing a substantial rare earth enriched carbonatite zone with promising grades and mineralogy akin to the Mountain Pass deposit.

Black Cat Syndicate reports visible antimony mineralisation in initial drill holes at Mt Clement, advancing one of Australia’s largest antimony deposits with assays due in November 2025.